RESUMO
Objective To analyze the Cost-effect of small cell lung cancer by drug economics.Methods 55 patients of small cell lung cancer were devided into 3 groups,CAV,PE and GP scheme,we evaluated the cost and effect based on drug economics.Results The effectiveness rate of CAV was 50 %,the cost of CAV was 340.76 yuan(RMB),the cost of 1 % increasing of effectiveness rate was 6.82 yuan(RMB);The effectiveness rate of PE was 71.9%,the cost of PE was 755.26 yuan(RMB),the cost of 1% increasing of effectiveness rate was 10.5 yuan(RMB);The effectiveness rate of GP was 85.7%,the cost of GP was 12 372.04 yuan(RMB),the cost of 1% increasing of effectiveness rate was 144.36 yuan(RMB).Conclusion PE is the most reasonable chemotherapy scheme for small cell lung cancer.